Compare AVTX & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | DOYU |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 203.7M |
| IPO Year | 2015 | 2019 |
| Metric | AVTX | DOYU |
|---|---|---|
| Price | $17.11 | $6.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $32.29 | $7.00 |
| AVG Volume (30 Days) | ★ 302.8K | 44.3K |
| Earning Date | 11-06-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 144.59% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $192,000.00 | ★ $566,928,371.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.39 | $5.68 |
| 52 Week High | $20.72 | $16.99 |
| Indicator | AVTX | DOYU |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 45.47 |
| Support Level | $15.49 | $6.73 |
| Resistance Level | $18.54 | $7.14 |
| Average True Range (ATR) | 1.17 | 0.21 |
| MACD | -0.28 | -0.01 |
| Stochastic Oscillator | 44.93 | 22.73 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.